ULBP2 Polyclonal antibody
ULBP2 Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
WB, ELISA
Conjugate
Unconjugated
Cat no : 31504-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | Jurkat cells, Saos-2 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:2000-1:10000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
31504-1-AP targets ULBP2 in WB, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | Recombinant protein 相同性解析による交差性が予測される生物種 |
Full Name | UL16 binding protein 2 |
Calculated molecular weight | 27 kDa |
Observed molecular weight | 30 kDa |
GenBank accession number | NM_025217.4 |
Gene symbol | ULBP2 |
Gene ID (NCBI) | 80328 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity Purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
ULBP2, or UL16-binding protein 2, is a member of the retinoic acid early transcript (RAET) family and serves as a ligand for the NKG2D receptor, which is expressed on natural killer (NK) cells, CD8+ T cells, and certain subsets of CD4+ T cells (PMID: 18791713). ULBP2 plays a critical role in the immune response by mediating natural killer cell cytotoxicity and is involved in antigen processing and presentation (PMID: 22102694; 21764762). ULBP2 has been implicated in various cancers and is associated with prognosis and immune infiltration in colon cancer (PMID: 36633827).
Protocols
Product Specific Protocols | |
---|---|
WB protocol for ULBP2 antibody 31504-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |